期刊文献+

肺结核患者耐多药监测结果分析 被引量:5

Analysis of monitoring results of multi-drug resistant pulmonary tuberculosis patients
下载PDF
导出
摘要 目的了解结核分枝杆菌耐药状况。方法在监测县收集结核菌株,用比例法进行4种抗结核药物异烟肼(INH)、链霉素(SM)、乙胺丁醇(EMB)、利福平(RFP)的药物敏感性测定。结果监测质量控制指标完成较好,388株结核分枝杆菌总耐药率为14.7%,耐多药率为4.6%。初始耐药率和获得性耐药率比较差异无统计学意义(P>0.05),初始耐多药率和获得性耐多药率比较差异有统计学意义(P<0.05)。4种抗结核药物的耐药率由高到低分别为INH(9.5%)、SM(7.7%)、RFP(6.7%)、EMB(2.3%)。不同性别组间的耐药率差异有统计学意义(P<0.05)。结论当前结核病控制工作取得一定成效,应继续贯彻以控制结核病传染源为重点,加强质量管理的措施,阻止耐药结核病的流行,定期监测,掌握耐药流行趋势,为评价和制订结核病控制措施提供科学依据。 Objective To understand the status of drug resistance of Mycobacterium tuberculosis. Methods Collection of Mycobacterium tuberculosis in monitoring the county, with the proportion of 4 kinds of anti-tuberculosis drug isoniazid (INH), streptomycin (SM), ethambutol (EMB), rifampicin (RFP) determination of the drug sensitivi- ty. Results Monitoring quality control indexes completed we11,388 strains of Mycobacterium tuberculosis total drug resistance rate was 14. 70//00 ,multiple drug resistance rate was 4.6%. The initial drug resistance and acquired resist- ance had no significant difference(P^0.05) ,there was significant difference in multi-drug resistant rate (P^0.05). Four kinds of anti-tuberculosis drug resistance rate from high to low were respectively IN H (9.5 ~), SM (7.7 ~ ), RFP (6.7 % ), EMB (2.3 % ). Drug resistance of different gender groups had significant difference(P^0.05). Con- clusion The current tuberculosis control work has achieved certain results, should continue to carry out to control tuberculosis infection source as the focus, strengthen quality management, prevent drug-resistant tuberculosis epidem- ic, regular monitoring of drug resistance,grasp the popular trend,to provide a scientific basis for evaluating and devel- oping tuberculosis control measures.
出处 《检验医学与临床》 CAS 2013年第13期1635-1637,共3页 Laboratory Medicine and Clinic
基金 贵州省科教青年英才培养工程基金支持[黔省专合字(2012)182号]
关键词 结核病 耐药 监测 tuberculosis drug resistanc monitoring
  • 相关文献

参考文献10

二级参考文献38

  • 1缪梓萍,郑锦雷,柳正卫,何海波,何铁牛,刘北斗.复治肺结核耐药性与用药史关系研究[J].中国防痨杂志,2008,30(4):304-307. 被引量:30
  • 2郭文玉,孙詠棠.结核菌原发耐药病例调查选例标准探讨[J].中国防痨杂志,1993,15(2):72-74. 被引量:28
  • 3结核病诊断细菌学检验规程[J].中国防痨杂志,1996,18(1):28-31. 被引量:799
  • 4柳正卫,何海波,缪梓萍,李群.984株结核分枝杆菌耐药情况分析[J].中国防痨杂志,2007,29(2):167-170. 被引量:33
  • 5Mohamed AA,Adalbert L,Mario R,et al,Guidelines for surveillance of drug resistance in tuberculosis.2nd ed.Geneva:WHO,2003:1-71.
  • 6World Health Organization.Guidelines for drug susceptibility testing for second-line anti-tuberculosis drugs for dots-plus.WHO/CDS/TB/2001.288.Geneva:WHO,2001.
  • 7World Health Organization.Policy guidance on drug-susceptibility testing (DST) of second-line antituberculosis drugs.WHO/HTM/TB/2008.392.Geneva:WHO,2008.
  • 8World Health Organization.Guidelines for surveillance of drug resistance in tuberculosis.4th ed.Geneva:WHO,2009:1-83.
  • 9中华人民共和国卫生部.全国结核病耐药性基线调查报告(2007-2008年).北京:人民卫生出版社,2010:1-8.
  • 10World Health Organization.Multidrug and extensively drugresistant TB (M/XDR-TB):2010 global report on surveillance and response.WHO/HTM/TB/2010.3.Geneva:WHO,2010.

共引文献184

同被引文献56

引证文献5

二级引证文献21

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部